Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | BHMT | Q93088 | 1/20 | 0.38 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30494619 | 1.00 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1MMEDPP4DPP8 | |
| SCHEMBL30494781 | 1.00 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1MMEDPP4DPP8 | |
| SCHEMBL3785069 | 1.00 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1MMEDPP4DPP8 | |
| SCHEMBL30567423 | 0.96 | BACE1 (0.40) | SMN1; SMN2ALDH1A1MMEDPP4DPP8 | |
| SCHEMBL29578129 | 0.96 | BACE1 (0.40) | SMN1; SMN2ALDH1A1MMEDPP4DPP8 | |
| SCHEMBL31181173 | 0.92 | ENPEP (0.44) | ENPEPBACE1 | |
| SCHEMBL30462197 | 0.89 | PDCD1LG2 (0.44) | MMEDPP4DPP8DPP9ENPEP | |
| SCHEMBL31307239 | 0.88 | BACE1 (0.45) | MMEBACE1 | |
| SCHEMBL8526326 | 0.87 | PDCD1LG2 (0.48) | MMEDPP4DPP8DPP9BHMT | |
| SCHEMBL29531923 | 0.87 | PDCD1LG2 (0.45) | SMN1; SMN2ALDH1A1MMEDPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4648799-A1 | LIGAND-DRUG CONJUGATES | Sun Pharma Advanced Research Company Ltd (IN) | 2025-11-19 | — | — | EP | claimed |
| EP-4605407-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | Endevica Bio, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| CN-119523057-A | Method for improving taste dipeptide content in salted fish | 海南大学三亚研究院 | 2025-02-28 | — | — | CN | claimed |
| CN-118409095-A | Metabolic markers for diagnosing the extent of coronary artery stenosis and uses thereof | 哈尔滨脉图精准技术有限公司 | 2024-07-30 | — | — | CN | claimed |
| WO-2024150132-A1 | LIGAND-DRUG CONJUGATES | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2024-07-18 | — | — | WO | claimed |
| WO-2024086381-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO, INC. (US) | 2024-04-25 | — | — | WO | claimed |
| CN-117838878-A | Antibody-STING agonist conjugates and their use in immunotherapy | 免疫传感器治疗股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115353551-B | Oat-derived GLP-1 secretion-promoting oligopeptide and preparation method and application thereof | 上海理工大学 | 2024-01-26 | — | — | CN | claimed |
| CN-117074700-A | Metabolic markers for diagnosing the extent of coronary artery stenosis and uses thereof | 哈尔滨脉图精准技术有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-117015381-A | Novel steroid payloads, steroid linkers, ADCs containing the same and uses thereof | 伊穆奈克斯特股份有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-115047120-B | Method for analyzing and detecting dansyl chloride derivative of dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4114417-A2 | THERAPEUTIC AGENTS AND CONJUGATES THEREOF | Beijing Xuanyi Pharmasciences Co., Ltd. (CN) | 2023-01-11 | — | — | EP | claimed |
| CN-115427051-A | Therapeutic agents and conjugates thereof | 北京轩义医药科技有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-115353551-A | Oat-derived GLP-1 secretion promoting oligopeptide and preparation method and application thereof | 上海理工大学 | 2022-11-18 | — | — | CN | claimed |
| CN-115047120-A | Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| US-20220257789-A1 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | EXELIXIS, INC. | 2022-08-18 | — | — | US | claimed |
| EP-3999118-A1 | ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN IMMUNOTHERAPY | Immunesensor Therapeutics, Inc. (US) | 2022-05-25 | — | — | EP | claimed |
| EP-3994150-A1 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | Iconic Therapeutics, Inc. (US) | 2022-05-11 | — | — | EP | claimed |
| CN-114222752-A | Anti-tissue factor antibody-drug conjugates and related methods | 伊科尼克治疗公司 | 2022-03-22 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257789-A1 | ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND RELATED METHODS | F3, F13B, TFPI | SMN1; SMN2 3706/4885ALDH1A1 1620/4885MME 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.